Presenting symptoms and clinical findings in HPV-positive and HPV-negative oropharyngeal cancer patients

Acta Otolaryngol. 2018 May;138(5):513-518. doi: 10.1080/00016489.2017.1405279. Epub 2017 Nov 21.

Abstract

Objectives: Oropharyngeal squamous cell carcinoma (OPSCC) is divided in two different disease entities depending on HPV involvement. We investigated differences in presenting symptoms and clinical findings in patients with HPV-positive and -negative OPSCC tumors.

Methods: Altogether 118 consecutive patients diagnosed with primary OPSCC between 2012 and 2014 at the Helsinki University Hospital were included. HPV-status of the tumors was assessed by PCR detection of HPV DNA and immunostaining with p16-INK4a antibody.

Results: Fifty-one (47.7%) of the patients had HPV-positive and 56 (52.3%) HPV-negative tumors. Forty-nine (49/51, 96.1%) of the HPV+ tumors were also p16+ showing high concordance. The most common presenting symptom among HPV+/p16+ patients was a neck mass (53.1%), whereas any sort of pain in the head and neck area was more frequently related to the HPV-/p16- (60.0%) group. HPV+/p16+ tumors had a tendency to locate in the tonsillar complex and more likely had already spread into regional lymph nodes compared with HPV-/p16- tumors. Smoking and heavy alcohol consumption were significantly more common among HPV−/p16− patients but also rather common among HPV+/p16+ patients [corrected].

Conclusions: This analysis of symptoms and signs confirm that OPSCC can be dichotomized in two distinct disease entities as defined by HPV status.

Keywords: Human papillomavirus; cancer; etiology; oropharynx; p16; symptom.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell / epidemiology
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / virology*
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Female
  • Finland / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Oropharyngeal Neoplasms / epidemiology
  • Oropharyngeal Neoplasms / metabolism
  • Oropharyngeal Neoplasms / virology*
  • Papillomavirus Infections / complications*
  • Retrospective Studies

Substances

  • Cyclin-Dependent Kinase Inhibitor p16